Surgical Intervention for Emphysematous Osteomyelitis of the Spine in a Patient with Malnutrition and Anemia: A Unique Case Study

• by Junyu Zhang, Siqi Feng, Zhiqiang Liu, Kan Xie, Chunli Gu, Jun Shen, Yangbo Zhang, Yunlong Zhou

• January 19, 2026

Health-economic evaluation of a novel personalized digital avatar-based anemia management software in hemodialysis patients

• by Afschin Gandjour, Dana Kendzia, Kevin Ho, Doris H. Fuertinger, Carsten Hornig, Christian Apel, Jovana Petrovic Vorkapic

• January 3, 2026

Dana-Farber Cancer Institute and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center recognized for exceptional outcomes in donor stem cell transplants

Dana-Farber Cancer Institute’s adult stem cell transplant program and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s pediatric stem cell transplant program have once again received exceptional ratings from the Center for International Blood & Marrow Transplant Research (CIBMTR), earning a +1 performance score, the highest possible designation, on their annual center-specific survival reports.

• by

• December 17, 2025

• 4 min

Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseases

• by Xiangke Xin, Wenli Zhang, Zhen Li, Ruirui Gui, Juan Wang, Liyun Ji, Yanli Zhang, Baijun Fang, Yongping Song, Yingling Zu, Jian Zhou

• February 5, 2025